Amgen Astellas BioPharma
Biopharmaceutical research and development
- B2B
About Amgen Astellas BioPharma
A joint venture between Amgen and Astellas, providing breakthrough medicines based on science to address unmet medical needs in Japan
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11–50 employees
- Headquarters
- Chiyoda-ku, Tokyo, Japan
- Founded
- 2013
- Revenue
- $7.2M – $41MTamtam estimate
- Website
- amgen.co.jp
Amgen Astellas BioPharma at a glance
Amgen Astellas BioPharma is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Chiyoda-ku, Tokyo, Japan.
Amgen Astellas BioPharma was founded in 2013.
Amgen Astellas BioPharma has 11–50 employees.
Amgen Astellas BioPharma's revenue is $7.2M – $41M (Tamtam estimate).
Frequently asked questions about Amgen Astellas BioPharma
What is Amgen Astellas BioPharma's revenue?
Tamtam estimates Amgen Astellas BioPharma's annual revenue at $7.2M – $41M.
How many employees does Amgen Astellas BioPharma have?
Amgen Astellas BioPharma has 11–50 employees.
Where is Amgen Astellas BioPharma headquartered?
Amgen Astellas BioPharma is headquartered in Chiyoda-ku, Tokyo, Japan.
Selling to companies like Amgen Astellas BioPharma?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies